| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/16/2002 | US6372751 Drugs with benzene and pyrimidine rings |
| 04/16/2002 | US6372724 Modulation of human mast cell activation |
| 04/16/2002 | US6372487 Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372258 Methods of spray-drying a drug and a hydrophobic amino acid |
| 04/16/2002 | US6372252 Containing quantity of medicine in immediate release layer and second portion in release-delay matrix of hydrophilic polymer and water insoluble polymer |
| 04/16/2002 | US6372197 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 04/16/2002 | CA2260413C Terpenoid lactone compounds and their production process |
| 04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028887A2 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours |
| 04/11/2002 | WO2002028867A2 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028860A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | WO2002028859A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 04/11/2002 | WO2002028856A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/11/2002 | WO2002028847A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028810A2 Retinoids for the treatment of emphysema |
| 04/11/2002 | WO2002028434A2 Use of a ppar delta activator for treating inflammatory conditions |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028378A1 Combination particles for the treatment of asthma |
| 04/11/2002 | WO2002028377A1 Ihnalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | WO2002028373A1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 04/11/2002 | WO2002028368A1 New combination for the treatment of asthma |
| 04/11/2002 | WO2002028349A2 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001082868A3 A medicinal aerosol formulation |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001039573A3 Novel use of lung surfactant for treating legionnaire's disease |
| 04/11/2002 | WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | US20020042513 Therapeutic compounds |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042435 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/11/2002 | US20020042431 Zwitterionic tachykinin receptor antagonists |
| 04/11/2002 | US20020042427 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 04/11/2002 | US20020042426 Novel basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | US20020042416 6-azauracil derivatives as IL-5 inhibitors |
| 04/11/2002 | US20020042407 Substituted porphyrins |
| 04/11/2002 | US20020042404 Use for budesonide and formoterol |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020041887 Immune response modifier compounds for treatment of TH2 mediated and related diseases |
| 04/11/2002 | US20020041873 Administering neutrotrophic factor inhibitor |
| 04/11/2002 | DE10048840A1 Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren Use of lipopeptides or lipoproteins in the treatment of lung infections and tumors |
| 04/11/2002 | DE10047486A1 Phenoxyphenyl Alkansulfonate Phenoxy-phenyl alkane |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2424761A1 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | CA2424621A1 Combination particles for the treatment of asthma |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | CA2424285A1 Use of lipopeptides or lipoproteins for the treatment of lung infections and lung tumours |
| 04/11/2002 | CA2424279A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423898A1 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/11/2002 | CA2421417A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195435A1 Truncated phosphodiesterase-7 polypeptides |
| 04/10/2002 | EP1195178A1 Immunotrophic preparation for treating adenotonsillary hypertrophy |
| 04/10/2002 | EP1195161A2 Anti-IgE vaccines |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194429A1 Potassium channel openers |
| 04/10/2002 | EP1194425A1 Substituted benzimidazole |
| 04/10/2002 | EP1194418A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194187A1 Antibody-based treatment for streptococcus pneumoniae infection |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |